Maintaining Efficacy But Decreasing Toxicity in the Treatment of Hodgkin Lymphoma

por Ansell, Stephen M.
Publicado 2017

Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies

por Bhardwaj, Vaishali, Ansell, Stephen M.
Publicado 2023

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance

por Paludo, Jonas, Ansell, Stephen M
Publicado 2017

Waldenström macroglobulinemia: biology, genetics, and therapy

por Paludo, Jonas, Ansell, Stephen M
Publicado 2016

CAR T-cells: Driving in the Fast Lane

por Ansell, Stephen M., Corradini, Paolo
Publicado 2019

Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors

por Joshi, Maansi, Ansell, Stephen M.
Publicado 2020

Role of the Bone Marrow Niche in Supporting the Pathogenesis of Lymphoid Malignancies

por Jalali, Shahrzad, Ansell, Stephen M.
Publicado 2021

Recent advances in the management of Hodgkin lymphoma

por Villasboas, Jose C., Ansell, Stephen M.
Publicado 2016

Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma

por Csizmar, Clifford M., Ansell, Stephen M.
Publicado 2021

Immune Epigenetic Crosstalk Between Malignant B Cells and the Tumor Microenvironment in B Cell Lymphoma

por Mondello, Patrizia, Ansell, Stephen M., Nowakowski, Grzegorz S.
Publicado 2022

Insights into the tumor microenvironment of B cell lymphoma

por Ng, Wern Lynn, Ansell, Stephen M., Mondello, Patrizia
Publicado 2022

Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective

por Villasboas, Jose Caetano, Ansell, Stephen M., Witzig, Thomas E.
Publicado 2016

CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges

por Narkhede, Mayur, Mehta, Amitkumar, Ansell, Stephen M., Goyal, Gaurav
Publicado 2021

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

por Wang, Yucai, Nowakowski, Grzegorz S., Wang, Michael L., Ansell, Stephen M.
Publicado 2018

Monoclonal gammopathy of undetermined significance: evaluation, risk assessment, management, and beyond

por Abeykoon, Jithma P, Tawfiq, Reema K, Kumar, Shaji, Ansell, Stephen M
Publicado 2022

Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies

por Ravi, Praful, Kumar, Shaji K., Cerhan, James R., Maurer, Matthew J., Dingli, David, Ansell, Stephen M., Rajkumar, S. Vincent
Publicado 2018

A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies

por Armand, Philippe, Lesokhin, Alexander, Borrello, Ivan, Timmerman, John, Gutierrez, Martin, Zhu, Lili, Popa McKiver, Mihaela, Ansell, Stephen M.
Publicado 2020

Interleukin-15 Affects Patient Survival through Natural Killer Cell Recovery after Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphomas

por Porrata, Luis F., Inwards, David J., Micallef, Ivana N., Johnston, Patrick B., Ansell, Stephen M., Hogan, William J., Markovic, Svetomir N.
Publicado 2010

Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation

por Porrata, Luis F., Inwards, David J., Ansell, Stephen M., Micallef, Ivana N., Johnston, Patrick B., Hogan, William J., Markovic, Svetomir N.
Publicado 2013

Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma

por Porrata, Luis F, Inwards, David J, Ansell, Stephen M, Micallef, Ivana N, Johnston, Patrick B, Hogan, William J, Markovic, Svetomir N
Publicado 2015